文献速递卫生政策与健康促进

在临床试验注册平台报告摘要结果:世界卫生组织更新指南

Reporting summary results in clinical trial registries: updated guidance from WHO.
PubMed 文献 · Lancet Glob Health · 2025-01-01

本文讨论在试验注册平台报告摘要结果的依据,回顾注册平台政策现状,并介绍2025年世界卫生组织(WHO)新指南;该指南经与研究者、患者、申办方、资助方、监管机构、期刊编辑、注册平台管理员及公众磋商后制定,定义所有试验均需报告的八项最低条目。

要点

  • WHO 2025年指南经多方磋商制定,定义所有试验摘要结果需报告的八项最低条目。
  • 注册平台实施、研究者与申办方广泛遵循及多方认可,可提升试验对科学知识、患者照护和卫生政策的贡献。
  • 尽管立法与资助方要求扩大,注册平台中结果可及性仍不常见,导致证据基础不完整和资源浪费。

核心结论

  • 实施WHO指南、研究者与申办方广泛遵循及资助方、监管机构、立法者、研究伦理委员会、患者组织和期刊认可,可帮助提升试验对科学知识、患者照护和卫生政策的贡献。

研究设计与样本

  • 本文讨论在试验注册平台报告摘要结果的依据,回顾注册平台政策现状,并呈现新的WHO指南。
  • 2025年WHO指南在与研究者、患者、申办方、资助方、监管机构、期刊编辑、注册平台管理员及公众等相关方磋商后制定。

主要发现

  • 尽管在入组前注册试验已取得实质性进展,但注册平台中结果的可及性仍不常见,导致证据基础不完整和资源浪费,尤其对未发表试验。
  • 2025年WHO指南定义了对理解和解释所有试验摘要结果必不可少的八项最低条目。

关键数值与推荐

  • 2025年WHO指南定义了所有试验摘要结果需报告的八项最低条目。

临床怎么用

  • 注册平台实施WHO指南、研究者与申办方广泛遵循及资助方、监管机构、立法者、研究伦理委员会、患者组织和期刊认可,可帮助提升试验对科学知识、患者照护和卫生政策的贡献。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The importance of publicly registering clinical trials and reporting their results in registries is widely recognised. While substantial progress has been made with registering trials before enrolment, the availability of results in registries remains uncommon despite expanding legislative and funder requirements-leading to an incomplete evidence base and avoidable waste of resources, particularly for unpublished trials. This paper discusses the rationale for reporting summary results in trial registries, reviews the current landscape of registry policies, and presents new WHO guidance for reporting results in registries. The 2025 WHO guidance was developed after consultation with relevant parties, including researchers, patients, sponsors, funders, regulators, journal editors, registry administrators, and the public. The guidance defines eight minimum items that are essential for understanding and interpreting the summary results for all trials. Implementation of the WHO guidance by trial registries, broad adherence by investigators and sponsors, and endorsement by funders, regulators, legislators, research ethics committees, patient organisations, and journals can help enhance the contribution of trials to scientific knowledge, patient care, and health policy.

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Chan AW, Karam G, Pymento J, et al. Reporting summary results in clinical trial registries: updated guidance from WHO. Lancet Glob Health. 2025. PMID: 40155113. doi:10.1016/S2214-109X(24)00514-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。